ClinConnect ClinConnect Logo
Search / Trial NCT06280872

Physiologically Based Cord Clamping To Improve Neonatal Outcomes In Moderate And Late Preterm Newborns

Launched by QUEEN FABIOLA CHILDREN'S UNIVERSITY HOSPITAL · Feb 19, 2024

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

Moderate And Late Preterm Newborn Neonatal Respiratory Morbidity Physiological Based Cord Clamping Mother Infant Bonding

ClinConnect Summary

This clinical trial is studying a technique called delayed cord clamping for babies born moderately or late preterm, which means they are born between 32 and 36 weeks of pregnancy. Normally, when a baby is born, the umbilical cord is clamped and cut right away, but this study is testing whether waiting a little longer to do this can help the baby breathe better and bond with their mother. When babies are born too early, their lungs may still be filled with fluid, making it hard for them to breathe. This technique may help them adapt better after birth, potentially reducing the need for extra medical help.

To participate in this trial, pregnant women must be expecting a single baby and be in the specified gestational age range. Women with certain health issues or complications, such as severe anemia or fetal distress, will not be eligible. Those who join the study can expect to have their baby's breathing and overall health monitored closely after birth, while also being able to stay near their baby during this important time. This research aims to find ways to improve health outcomes for preterm infants and strengthen the bond between mother and child.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Pregnant women followed-up in Brugmann University Hospital will be eligible to participate if:
  • The delivery takes place between 32 0/7 and 36 6/7 weeks of gestation
  • They carry singletons
  • Exclusion Criteria:
  • Fetal anomalies including congenital malformations, anemia, and growth restriction with abnormal Dopplers.
  • Abnormal placentation such as placenta previa.
  • Signs of fetal distress necessitating an emergency cesarean section.
  • Maternal health issue including severe anemia (defined as hemoglobin level \< 7 g/dL), preeclampsia, and bleeding disorders.
  • Maternal refusal of the use of blood products.
  • General anesthesia for cesarian section.
  • Planned cord blood banking.
  • Total language barrier without possibility of translation

About Queen Fabiola Children's University Hospital

Queen Fabiola Children's University Hospital is a premier pediatric institution dedicated to advancing child health through innovative clinical research and compassionate care. As a leading sponsor of clinical trials, the hospital focuses on developing and evaluating new treatments and therapies for various pediatric conditions. With a multidisciplinary team of experienced clinicians and researchers, the institution fosters a collaborative environment that emphasizes patient safety, ethical standards, and the integration of cutting-edge scientific advancements. Through its commitment to enhancing pediatric healthcare, Queen Fabiola Children's University Hospital aims to improve outcomes for children and adolescents on a global scale.

Locations

Brussels, , Belgium

Brussels, , Belgium

Patients applied

0 patients applied

Trial Officials

Anna AMORUSO

Principal Investigator

HUDERF

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported